share_log

Brookline Capital:上调Dare Bioscience(DARE.US)评级,由持有调整至买入评级, 目标价3.00美元。

Brookline Capital: Upgraded Dare Bioscience (DARE.US) rating from holding to buying, with a target price of $3.00.

Zhitong Finance ·  May 15 18:27
Brookline Capital: Upgraded Dare Bioscience (DARE.US) rating from holding to buying, with a target price of $3.00.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment